NASDAQ:NUTX
Nutex Health Inc.
Nutex Health Inc.'s revenue grew 82.4% in fiscal 2025 to $875.3M while operating margin rose to 31.5%. Free cash flow was $245.6M, 28.1% of revenue, and the diluted share count rose 23.0%.Summary generated from Nutex Health Inc.'s SEC filings. Latest annual report filed Mar 5, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$875.3M
Revenue growth+82.4%
Revenue, 5-yr CAGR+26.1%
Gross margin50.8%
Operating margin31.5%
Net margin8.1%
ROIC128.9%
Return on equity30.7%
Debt / equity0.13
Free cash flow$245.6M
FCF margin28.1%
Share count change+23.0%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 332 | 219 | 248 | 480 | 875 |
| Operating income | 170 | −407 | −32 | 131 | 276 |
| Net income | 133 | −425 | −46 | 52 | 71 |
| Free cash flow | 137 | 36 | −8 | 21 | 246 |
Recent filings
- 4Insider transaction report
Sep 18, 2026 - 8-KOther events
Sep 11, 2026 - 8-KCurrent report
Aug 31, 2026 - 8-KOther events
Aug 24, 2026 - 8-KOther events
Aug 13, 2026 - 8-KResults of operations and financial condition
Aug 6, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 6, 2026 - 4Insider transaction report
Aug 3, 2026